PhD Openings

Please see our list of available projects below for the 2023/2024 academic year. Once you know which project(s) you wish to apply for, please also see our How to Apply pages before submitting your applications. Please note we will only accept applications for projects that are currently open, so please make sure to check the deadlines below.

All projects are fully funded, including tuition fees and a minimum tax-free annual living allowance of £18,622 (2023-24 UKRI rate). An additional allowance will be provided to contribute towards consumables, equipment, and travel related to the project.

Please note: Our quota for international awards has been filled for 2023/24. Please check your eligibility before applying.   

Code Project Title Supervisor Institution Deadline
mos23_16 mos23_16 PROTACS new computational methods, targets and experimental validation Ehmke Pohl  Durham

Closed
         
mos23_01   mos23_01 Synthetic antimicrobials based on natural toxins Tim Blower Durham

Closed
mos23_02   mos23_02 Development of a new approach to targeted chelation therapies Will Brittain Durham

Closed
mos23_03 mos23_03 DUNeS: Structure based development of dual specificity inhibitors of NLRP3 and SARM1 Agnieszka Bronowska     Newcastle     

Closed
mos23_04 mos23_04 Development of DNA-PK-targeting PROTACs to maximise DNA-PK blockage in advanced prostate cancer Celine Cano Newcastle

Closed
mos23_05 mos23_05 Identification of new molecular targets for NTDs Steven Cobb Durham

Closed
mos23_06 mos23_06 Differential diagnostics for leishmaniasis - bench to field Paul Denny Durham

Closed
mos23_07 mos23_07 Cell- and Tissue-targeted cyclic peptide discovery platform Akane Kawamura Newcastle

Closed
mos23_08 mos23_08 Ribosomal glycopeptide production to investigate glycosylation changes in prostate cancer Tom McAllister Newcastle

Closed
mos23_09 mos23_09 Structure guided approach to assay development for inhibiting Dengue virus replication Liz Morris Durham

Closed
mos23_10 mos23_10 Mass spectrometry approaches to address capability gaps in drug discovery for membrane transporters Matthias Trost Newcastle

Closed
mos23_11 mos23_11 Proteomics-based assessment of drug performance in vivo by establishing target engagement methods and characterizing new disease models Matthias Trost Newcastle

Closed
mos23_12 mos23_12 Lead optimization by DNA-encoding Mike Waring Newcastle

Closed
mos23_13 mos23_13 Expanding the Build-Couple-Transform Paradigm to develop highly diverse screening libraries for Drug Discovery Mike Waring Newcastle

Closed
mos23_14 mos23_14 CRISPR-mediated tagging of endogenous proteins for structural mapping of interactions Wyatt Yue Newcastle

Closed
mos23_15 mos23_15 DNA Nanosensors for Metal Ion Cancer Biomarkers Harold Fellerman Newcastle

Closed